The data indicates a steady increase in the standardized mortality rate of liver malignant neoplasms in Canada from 8.6 deaths per hundred thousand persons in 2024 to 9.0 in 2028. From 2023 to 2024, no data is available, but assuming continuity, these forecasted rates suggest a gradual annual increase of approximately 1.15%. Over the projected five-year period from 2024 to 2028, the compound annual growth rate (CAGR) is approximately 1.14%.
Future trends to watch for include advancements in medical treatment and prevention, public health initiatives, early diagnosis efforts, and changes in lifestyle factors, all of which could potentially influence mortality rates. Increased awareness and treatment options might positively impact future projections.
